Co-Founder & CSO
Profile summary: MBA at Columbia Business School
Able Sciences focuses on advancing cell engineering to develop next-generation therapeutic cells. The company aims to improve the efficacy and potential of cellular treatments for various diseases. Their work centers on refining the processes used to create these specialized fighting cells.
Raised to date
$275KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 1 round

$275K · Seed
Announced Jan 2024
Disclosed cumulative: $275K